Iterum Therapeutics rights offering expires; expects $7.4M gross proceeds

Iterum Therapeutics plc

Rights offering expired Aug 6, 2024; gross proceeds est. $7.4M, net ~$6.3M after $1.1M expenses.
17,007,601 rights distributed; each allowed purchase of 0.50 Units at $0.605.
Basic subscription: 6,121,965 Units; over-subscription of 5,091,550 Units fully honored.
Each Unit includes 1 share, 0.50 1-yr warrant ($1.21 strike), and 1 5-yr warrant ($1.21).
Shares and warrants expected to be delivered on or about Aug 9, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.